Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VictrexVTXPF 71 3-Year ROIIC % is 219.01 as of Sep. 2025, which is 9548% above its 10-year median of 2.27. GuruFocus rates VTXPF with a GF Score™ of 71/100 and a GF Value™ of $14.69 (Significantly Undervalued). The stock has 10 warning signs investors should review. Among 1,522 Chemicals companies, Victrex ranks better than 96.25% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Victrex's 3-Year ROIIC % for the quarter that ended in Sep. 2025 was 219.01%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Victrex's 3-Year ROIIC % or its related term are showing as below:
VTXPF's 3-Year ROIIC % is ranked better than 96.25% of 1522
companies
in the Chemicals industry
Industry Median: -0.04
vs VTXPF: 219.01
Victrex (OTCPK:VTXPF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Victrex 3-Year ROIIC % Related Terms
Victrex 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Victrex's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Victrex's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Victrex 3-Year ROIIC % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Victrex's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Victrex's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Victrex (VTXPF) has a 3-Year ROIIC % of 219.01 as of Sep. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Victrex and its competitors. This is 9548% above median its historical median of 2.27. According to the industry distribution chart, Victrex ranks #57 out of 1522 companies in the Chemicals industry, placing it in the top 3.7%.
Is Victrex's 3-Year ROIIC % too high?
Victrex's current 3-Year ROIIC % of 219.01 is 9548% above median its 10-year median of 2.27. Based on the distribution chart, Victrex ranks #57 out of 1522 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Victrex has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Victrex's 3-Year ROIIC % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Victrex ranks #57 out of 1522 companies for 3-Year ROIIC %. This places Victrex in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Chemicals company?
A good 3-Year ROIIC % depends on the Chemicals industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Victrex and its competitors. Victrex's current 3-Year ROIIC % is 219.01, which is 9548% above median its own 10-year median of 2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Victrex stock overvalued right now?
Based on GuruFocus' analysis, Victrex (VTXPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.69, compared to a current price of $9.12 — trading 37.9% below its estimated fair value. The current 3-Year ROIIC % is 219.01, which is 9548% above median its 10-year median of 2.27. Victrex's overall GF Score™ is 71/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Victrex (VTXPF), the current 3-Year ROIIC % is 219.01 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Victrex (VTXPF) Overvalued in 2026?
Based on GuruFocus' analysis, Victrex stock appears to be undervalued.
The current stock price of $9.12 is trading 37.9% below its estimated GF Value™ of $14.69.
GuruFocus considers Victrex to be Significantly Undervalued.
Key valuation signals for VTXPF:
3-Year ROIIC %: 219.01 (9548% above median its 10-year median of 2.27)
GF Value™: $14.69 vs. price of $9.12 (37.9% below fair value)
No single metric tells the full story. See the VTXPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Victrex PLC is a British specialty chemicals company whose business is based predominantly on manufacturing and creating solutions using polyetheretherketone, or PEEK, an ultra-high-performance lightweight plastic. The business has two segments. The Sustainable Solutions targets transportation, energy, electronics, and manufacturing, while the Medical Segment provides healthcare solutions for the implantable device markets. Geographically operates in the United Kingdom, Europe, the Middle East and Africa (EMEA), America, and Asia-Pacific. Its maximum sales are generated from the Middle East and Africa (EMEA).
71GF Score
Get the complete analysis for VTXPF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTXPF has been successfully added to your 
